Evidence map›Paper›PMID 38903011›Full record

ArticleDisease models & mechanisms2024

Muscle-specific lack of Gfpt1 triggers ER stress to alleviate misfolded protein accumulation.

Ruchen Zhang, Paniz Farshadyeganeh, Bisei Ohkawara, Kazuki Nakajima, Jun-Ichi Takeda, Mikako Ito, Shaochuan Zhang, Yuki Miyasaka, Tamio Ohno, Madoka Mori-Yoshimura and 2 more

Abstract read
In one paragraph

Article in Disease models & mechanisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ruchen ZhangDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Paniz FarshadyeganehDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Bisei OhkawaraDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Kazuki NakajimaInstitute for Glyco-core Research (iGCORE), Gifu University, Gifu 501-1193, Japan.
Jun-Ichi TakedaDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Mikako ItoDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Shaochuan ZhangDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Yuki MiyasakaDivision of Experimental Animals, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Tamio OhnoDivision of Experimental Animals, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Madoka Mori-YoshimuraDepartment of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira 187-8775, Japan.
Akio MasudaDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.ORCID 0000-0002-6437-2853
Kinji OhnoDivision of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.ORCID 0000-0002-1529-2750

Funding

Japan Agency for Medical Research and Development JP23ek0109678Japan Society for the Promotion of Science JP23H02794Ministry of Health, Labour and Welfare 23FC1014Nagoya UniversityNational Center of Neurology and Psychiatry 5-6THERS Interdisciplinary Frontier Next Generation Researcher Project
6 · The paper itself

Abstract

Pathogenic variants in GFPT1, encoding a key enzyme to synthesize UDP-N-acetylglucosamine (UDP-GlcNAc), cause congenital myasthenic syndrome (CMS). We made a knock-in (KI) mouse model carrying a frameshift variant in Gfpt1 exon 9, simulating that found in a patient with CMS. As Gfpt1 exon 9 is exclusively expressed in striated muscles, Gfpt1-KI mice were deficient for Gfpt1 only in skeletal muscles. In Gfpt1-KI mice, (1) UDP-HexNAc, CMP-NeuAc and protein O-GlcNAcylation were reduced in skeletal muscles; (2) aged Gfpt1-KI mice showed poor exercise performance and abnormal neuromuscular junction structures; and (3) markers of the unfolded protein response (UPR) were elevated in skeletal muscles. Denervation-mediated enhancement of endoplasmic reticulum (ER) stress in Gfpt1-KI mice facilitated protein folding, ubiquitin-proteasome degradation and apoptosis, whereas autophagy was not induced and protein aggregates were markedly increased. Lack of autophagy was accounted for by enhanced degradation of FoxO1 by increased Xbp1-s/u proteins. Similarly, in Gfpt1-silenced C2C12 myotubes, ER stress exacerbated protein aggregates and activated apoptosis, but autophagy was attenuated. In both skeletal muscles in Gfpt1-KI mice and Gfpt1-silenced C2C12 myotubes, maladaptive UPR failed to eliminate protein aggregates and provoked apoptosis.

Indexed as

AutophagyEndoplasmic Reticulum StressMuscle, SkeletalProtein FoldingUnfolded Protein ResponseAnimalsApoptosisForkhead Box Protein O1Gene Knock-In TechniquesGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)MiceMuscle Fibers, SkeletalNeuromuscular JunctionOrgan SpecificityProteasome Endopeptidase ComplexProtein AggregatesForkhead Box Protein O1Gfpt1 protein, mouseGlutamine-Fructose-6-Phosphate Transaminase (Isomerizing)Proteasome Endopeptidase ComplexProtein AggregatesX-Box Binding Protein 1Congenital myasthenic syndrome (CMS)Endoplasmic reticulum (ER) stressGlutamine fructose-6-phosphate transaminase 1 (GFPT1)Hexosamine biosynthesis pathway (HBP)Neuromuscular junction (NMJ)Unfolded protein response (UPR)

Identifiers

PMID38903011
PMCPMC11554261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.